Cargando…

Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming

Safe and effective T cell vaccines are needed for the treatment or prevention of cancers as well as infectious agents where vaccines for neutralizing antibodies have performed poorly. Recent research highlights an important role for tissue-resident memory T cells (T(RM) cells) in protective immunity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viscidi, Raphael P., Rowley, Treva, Bossis, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298155/ https://www.ncbi.nlm.nih.gov/pubmed/37372999 http://dx.doi.org/10.3390/ijms24129851

Ejemplares similares

Erythro-VLP: Erythrocyte Virus-Like-Particles
por: Himbert, Sebastian, et al.
Publicado: (2021)

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
por: Huber, Bettina, et al.
Publicado: (2017)

Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses
por: Ye, Ling, et al.
Publicado: (2010)

Immunotherapy targeting the PD-1 pathway alleviates neuroinflammation caused by chronic Toxoplasma infection
por: Xiao, Jianchun, et al.
Publicado: (2023)

Zika virus-like particle (VLP) based vaccine
por: Boigard, Hélène, et al.
Publicado: (2017)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023)

Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas
por: Govan, Vandana A, et al.
Publicado: (2008)

On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLP
por: Roldão, António, et al.
Publicado: (2012)

VLP‐factory™ and ADDomer(©): Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display
por: Sari‐Ak, Duygu, et al.
Publicado: (2021)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
por: Klimek, Ludger, et al.
Publicado: (2018)

Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen
por: Singh, V, et al.
Publicado: (2012)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
por: Torresi, Joseph
Publicado: (2017)

Human Papillomavirus Type16- L1 VLP Production in Insect Cells
por: Abdoli, Asghar, et al.
Publicado: (2013)

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
por: Schellenbacher, Christina, et al.
Publicado: (2013)

Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions
por: Antanasijevic, Aleksandar, et al.
Publicado: (2016)

A Hydrodynamic Approach to the Study of HIV Virus-Like Particle (VLP) Tangential Flow Filtration
por: Wolf, Tobias, et al.
Publicado: (2022)

Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines
por: Fernandez, F.M., et al.
Publicado: (1998)

Epidemiological study of bovine norovirus infection by RT-PCR and a VLP-based antibody ELISA
por: Mauroy, Axel, et al.
Publicado: (2009)

Bioengineering of Virus-like Particles for the Prevention or Treatment of Allergic Diseases
por: Pechsrichuang, Phornsiri, et al.
Publicado: (2020)

A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system
por: Pankrac, Joshua, et al.
Publicado: (2018)

Virus-like Particle (VLP) Mediated Antigen Delivery as a Sensitization Tool of Experimental Allergy Mouse Models
por: Kim, Juhyung, et al.
Publicado: (2020)

Induction of a CD8(+) Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4(+) T Cell Help
por: Bennett, Sally R.M., et al.
Publicado: (1997)

Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement
por: Schmidt, Frederik L., et al.
Publicado: (2021)

Bioengineered Ciprofloxacin-Loaded Chitosan Nanoparticles for the Treatment of Bovine Mastitis
por: Yadav, Preeti, et al.
Publicado: (2022)

Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
por: Garg, Himanshu, et al.
Publicado: (2020)

Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains
por: Chu, Ki-Back, et al.
Publicado: (2021)

Coronavirus Immunoreactivity in Individuals With a Recent Onset of Psychotic Symptoms
por: Severance, Emily G., et al.
Publicado: (2011)

RNA Phage VLP-Based Vaccine Platforms
por: Peabody, David S., et al.
Publicado: (2021)

Cd8(+) but Not Cd8(−) Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo
por: den Haan, Joke M.M., et al.
Publicado: (2000)

Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins
por: Serradell, Marianela C., et al.
Publicado: (2019)

Mechanistic and structural basis of bioengineered bovine Cathelicidin-5 with optimized therapeutic activity
por: Sahoo, Bikash R., et al.
Publicado: (2017)

Development of a novel platform of virus-like particle (VLP)-based vaccine against COVID-19 by exposing epitopes: an immunoinformatics approach
por: Ghorbani, A., et al.
Publicado: (2020)

Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice
por: Zhou, Hongli, et al.
Publicado: (2011)

Large-scale production and purification of VLP-based vaccines
por: Vicente, Tiago, et al.
Publicado: (2011)

Papillomavirus-like Particles in Equine Medicine
por: Hainisch, Edmund K., et al.
Publicado: (2023)

A Human Trypanosome Suppresses CD8(+) T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4(+) Foxp3(+) T Cells
por: Ersching, Jonatan, et al.
Publicado: (2016)

LB18. An Enveloped Virus-like Particle (eVLP) Cytomegalovirus (CMV) Vaccine Is Immunogenic and Safe: Results of a First-in-Humans Study
por: Gantt, Soren, et al.
Publicado: (2018)

Helpless Priming Sends CD8(+) T Cells on the Road to Exhaustion
por: Busselaar, Julia, et al.
Publicado: (2020)

Abnormally primed CD8 T cells: The Achilles’ heel of CHB
por: Chen, Xiaoqing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_946a0917h9bkoi79iebr3mj9e4